The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

1. The relationships between renal creatinine clearance and the renal clearances of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) were studied in fifteen intensive-care patients who were receiving morphine sulphate by constant intravenous infusion and who had diverse renal function. 2. An arterial blood sample was collected before and after a 4-5 h urine collection. Plasma and urine concentrations of morphine, M3G and M6G were measured by h.p.l.c. Plasma binding of all three compounds in drug-free plasma from healthy volunteers was determined by ultrafiltration. Measured renal creatinine clearance (CLCr,meas) was calculated from plasma and urinary creatinine concentrations (from h.p.l.c.). Also, creatinine clearance was predicted (CLCr,pred) from routine laboratory determination of plasma creatinine (Jaffe method). 3. There were significant linear relationships (P less than 0.001) between CLCr,meas and the renal clearances of morphine, M3G and M6G. The unbound renal clearance of morphine exceeded CLCr,meas (P less than 0.002) while the unbound renal clearances of M3G and M6G did not differ from CLCr,meas (P greater than 0.5). 4. In ten of the patients who received a constant infusion of morphine for at least 6 h, the dose-normalised plasma concentrations of M3G and M6G increased with decreasing CLCr,pred. Significant (P less than 0.001) relationships were observed between the reciprocal of CLCr,pred and the dose-normalised plasma concentrations of M3G and M6G. 5. The results indicate the importance of renal function in determining the renal clearances and plasma concentrations of M3G and M6G during intravenous infusion with morphine in intensive-care patients.

[1]  A. Somogyi,et al.  High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies. , 1991, Journal of chromatography.

[2]  T. Hedner,et al.  Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. , 1991, European journal of pharmacology.

[3]  Maree T. Smith,et al.  Morphine-3-Glucuronide — A potent antagonist of morphine analgesia , 1990, Pain.

[4]  G. Matzke,et al.  Validity of creatinine clearance estimates in the assessment of renal function , 1990, Clinical pharmacology and therapeutics.

[5]  F. Gouin,et al.  Assessment of creatinine clearance in intensive care patients. , 1990, Critical care medicine.

[6]  S. Joel,et al.  Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide , 1990, Clinical pharmacology and therapeutics.

[7]  R. Albrecht,et al.  Ventilatory effects of fourth cerebroventricular infusions of morphine-6- or morphine-3-glucuronide in the awake dog. , 1989, Anesthesiology.

[8]  G. Pasternak,et al.  Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. , 1989, The Journal of pharmacology and experimental therapeutics.

[9]  J. Hasselström,et al.  Long lasting respiratory depression induced by morphine-6-glucuronide? , 1989, British journal of clinical pharmacology.

[10]  S. Joel,et al.  ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDE , 1988, The Lancet.

[11]  G. Pasternak,et al.  Morphine-6-glucuronide, a potent mu agonist. , 1987, Life sciences.

[12]  M. Slevin,et al.  Morphine intoxication in renal failure; the role of morphine-6-glucuronide. , 1986, British medical journal.

[13]  K. Lynn,et al.  Renal failure does not impair the metabolism of morphine. , 1986, British journal of clinical pharmacology.

[14]  J P Kriss,et al.  Limitations of creatinine as a filtration marker in glomerulopathic patients. , 1985, Kidney international.

[15]  H. McQuay,et al.  Metabolism of narcotics. , 1984, British medical journal.

[16]  W. L. Chiou,et al.  Creatinine XII: comparison of assays of low serum creatinine levels using high-performance liquid chromatography and two picrate methods. , 1983, Journal of pharmaceutical sciences.

[17]  A. Rane,et al.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. , 1982, Journal of chromatography.

[18]  R. Branch,et al.  Normal metabolism of morphine in cirrhosis. , 1981, Gastroenterology.

[19]  E. R. Garrett,et al.  Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose. , 1979, Journal of pharmaceutical sciences.

[20]  H. Krebs,et al.  Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans. , 1977, Journal of pharmaceutical sciences.

[21]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[22]  H. Don,et al.  Narcotic analgesics in anuric patients. , 1975, Anesthesiology.

[23]  W. Bennett,et al.  Morphine and phenytoin binding to plasma proteins in renal and hepatic failure , 1975, Clinical pharmacology and therapeutics.

[24]  J. Fujimoto,et al.  Inhibition of renal tubular transport of morphine by -diethylaminoethyl diphenylpropylacetate in the chicken. , 1971, Biochemical pharmacology.

[25]  K. Oguri,et al.  Analgesic effect of morphine glucuronides. , 1971, The Tohoku journal of experimental medicine.

[26]  H. Husdan,et al.  Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. , 1968, Canadian Medical Association journal.

[27]  J. Fujimoto,et al.  The tubular transport and metabolism of morphine-N-methyl-C14 by the chicken kidney. , 1967, The Journal of pharmacology and experimental therapeutics.

[28]  R. Palmour,et al.  Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. , 1988, Life sciences.

[29]  Y. Mallédant,et al.  Perfusion intraveineuse prolongée de morphine. Etude pharmacocinétique , 1987 .